Category :   Corporate Information

LETROMARA — NEW PRODUCT FROM «FARMAK» FOR HORMONAL THERAPY OF PATIENTS WITH BREAST CANCER

№8 4 2006 262

NAVELBINE EFFICIENCY IN ONCOHEMATOLOGICAL PATHOLOGY

Authors:Gartovskaya I.R. №8 4 2006 1

CALUMID — NEW PREPARATION BY «RICHTER GEDEON» FOR THE DIFFUSE PROSTATE CANCER TREATMENT

№8 3 2006 31

LONG‑TERM INFUSION OF DOCETAXEL (TAXOTERE) DURING 2ND LINE POLYCHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE SOLID TUMORS

Authors:Kovtun V.A. Gayevoy K.V. Sevidov V.V. №8 3 2006 3

THE USE OF MASTODYNON FOR PROPHILAXIS AND THERAPY OF THE PATIENTS WITH DYSHORMONAL HYPERPLASIA OF MAMMARY GLAND

№9 4 2007 1

MODERN approaches TO treatment of anemia in patients with malignant neoplasms

Authors:Bessmeltsev S.S. №10 2 2008 No views

ANAEMIC SYNDROME IN HEMATO LOGICAL DISEASES CLINICAL RECOMMENDATIONS, PREVENTION AND TREATMENT

Authors:Kryachok I.A. Tytorenko I.B. Martynchik A.V. Filonenko K.S. ... №12 1 2010 2

FILSTIM (FILGRASTIM) APPLICATION IN TREATMENT OF HIGH RISK PATIENTS WITH HODGKIN’S LYMPHOMAS

Authors:Kryachok I.A. Martynchik A.V. Tytorenko I.B. Filonenko K.S. ... №12 1 2010 45

A MULTICENTRE STUDY OF PACLITAXEL AS TREATMENT OF OVARIAN CANCER

№13 1 2011 2

BARRIER DISPOSABLE OPERATING COVERS — METHOD OF PROPHYLAXIS OF POSTOPERATIVE INFECTIONS: EFFECTIVENESS, ECONOMICAL ADVANTAGES

Authors:Delikatny O.V. №14 5 2012 1

1234»